Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis

V Zarrouk1, A Feydy, F Sallès

  • 1Department of Internal Medicine, AP-HP, Beaujon Hospital, France.

Abstract

Insights

Persistent imaging abnormalities are common in bacterial spondylodiscitis patients even after successful treatment. These findings do not indicate relapse or complications, suggesting imaging follow-up may not be necessary with favorable clinical response.

Area of Science:

  • Infectious Diseases
  • Radiology
  • Orthopedics

Background:

  • Bacterial spondylodiscitis diagnosis often relies on MRI and CT scans.
  • The clinical significance of imaging changes during treatment requires further documentation.

Purpose of the Study:

  • To evaluate the persistence and clinical relevance of imaging abnormalities in bacterial spondylodiscitis after treatment.

Main Methods:

  • Prospective enrollment of 29 patients with bacterial spondylodiscitis from 1997-2005.
  • Clinical, biological, and imaging (MRI/CT) assessments at baseline, 3 months, and 6 months.
  • Median follow-up of 18 months, including 12 months post-treatment.

Main Results:

  • All patients achieved clinical cure with average 98-day antibiotic treatment.
  • Inflammatory markers normalized by 3 months.
  • Persistent imaging abnormalities (vertebral edema, disc/paravertebral abscesses) were observed at 3 and 6 months, but did not correlate with sequelae.

Conclusions:

  • Imaging abnormalities frequently persist after successful bacterial spondylodiscitis treatment.
  • Persistent imaging findings are not associated with relapse, neurological sequelae, or pain.
  • Routine imaging follow-up is unnecessary for favorably responding bacterial spondylodiscitis cases.